Vertex Pharmaceuticals (VRTX) Net Margin (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted quarterly Net Margin of 34.53% for Q1 2026, up 1120.0% year-over-year from 2.83% in Q1 2025, and down 7.52% quarter-over-quarter from 37.34% in Q4 2025.
Vertex Pharmaceuticals (VRTX) Net Margin (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals' Net Margin history runs 17 years deep, the most recent figure standing at 34.53% for Q1 2026.
- In Q1 2026, Net Margin rose 1120.0% year-over-year to 34.53%; the TTM figure through Mar 2026 stood at 35.51% (up 4442.0% YoY), while the FY2025 annual figure was 32.94%, up 3780.0% from the prior year.
- Net Margin for Q1 2026 stood at 34.53%, down from 37.34% in the prior quarter.
- The five-year high for Net Margin was 41.69% in Q3 2023, with the low at 135.83% in Q2 2024.
- The 5-year median for Net Margin is 36.33% (2022), against an average of 25.55%.
- The sharpest annual moves came in 2024 and 2025: Net Margin slumped 17256 bps in 2024, then soared 17067 bps in 2025.
- Vertex Pharmaceuticals' Net Margin stood at 35.56% in 2022, then gained by 8 bps to 38.48% in 2023, then declined by 19 bps to 31.35% in 2024, then climbed by 19 bps to 37.34% in 2025, then dropped by 8 bps to 34.53% in 2026.
- Business Quant data shows VRTX's Net Margin at 34.53% in Q1 2026, 37.34% in Q4 2025, and 35.2% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 30.33% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.90% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 30.98% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 12.74% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -3.12% |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -20,152.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.99% |
| Mar 31, 2026 | 34.53% |
| Dec 31, 2025 | 37.34% |
| Sep 30, 2025 | 35.20% |
| Jun 30, 2025 | 34.84% |
| Mar 31, 2025 | 23.33% |
| Dec 31, 2024 | 31.35% |
| Sep 30, 2024 | 37.71% |
| Jun 30, 2024 | -135.83% |
| Mar 31, 2024 | 40.87% |
| Dec 31, 2023 | 38.48% |
| Sep 30, 2023 | 41.69% |
| Jun 30, 2023 | 36.73% |
| Mar 31, 2023 | 29.47% |
| Dec 31, 2022 | 35.56% |
| Sep 30, 2022 | 39.86% |
| Jun 30, 2022 | 36.90% |
| Mar 31, 2022 | 36.33% |
| Dec 31, 2021 | 37.16% |
| Sep 30, 2021 | 42.94% |